Clinical Trials for Evergreen Therapeutics

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Evergreen Therapeutics

Clinical Trials (4)

NCT05077215
Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial Cancer
PHASE3Not yet recruiting
450 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor0 locations
NCT05106127
Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem
PHASE2Not yet recruiting
28 participants
Started: Aug 31, 2025 · Completed: Mar 31, 2026
1 condition1 sponsor0 locations
NCT05170048
Study to Evaluate Safety and Efficacy of EG-301 in Patients with Nonfocal Geographic Atrophy Secondary to DAMD
PHASE2Not yet recruiting
90 participants
Started: Jun 30, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor0 locations
NCT03527472
Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus
PHASE2Active, not recruiting
111 participants
Started: Aug 23, 2018 · Completed: Dec 31, 2025
1 condition4 sponsors3 locations